Cambian Group (CMBN) Share Price, News & Analysis

Company Overview

Cambian Group plc, together with its subsidiaries, provides specialist educational and behavioral health services for children in the United Kingdom. It offers services in the areas of autism and learning difficulties, residential care and education, therapeutic fostering care and emotional support, and deaf. The company delivers its services through a network of 222 specialist children's facilities in England and Wales. In addition, it is involved in property and trading businesses. The company was formerly known as Project Zelda plc and changed its name to Cambian Group plc in March 2014. Cambian Group plc was founded in 2003 and is based in London, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 54,471 shs
• Average Volume: 111,905 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CMBN Stock Analysis - Frequently Asked Questions

How do I buy shares of Cambian Group?

Shares of CMBN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Cambian Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cambian Group investors own include CareTech (CTH), Adtalem Global Education (ATGE), EnQuest (ENQ), Medicx Fund (MXF), Target Healthcare REIT (THRL), (UPLMQ) (UPLMQ) and Welltower (WELL).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Care
• Sub-Industry: N/A
• Current Symbol: LON:CMBN
• CIK: N/A
• Web: www.cambiangroup.com
• Phone: +44-20-87356150
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A